Bala Mohan

SVP, Chief Development Officer at Mersana Therapeutics, Inc.

Sold, on record
$49k
Dollars the filings state
Form 4 sales
7
Latest Oct 27, 2025
Form 144 notices
5
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 144 notice Mersana Therapeutics, Inc.Notice
    Oct 7, 2024 2024

    Filed to sell 13,687 shares ($28k)

    Bala Mohan, Officer

    10b5-1 plan4x usual sizeFiling

  2. 2 Form 4 sale Mersana Therapeutics, Inc.Routine
    Oct 28, 2024 +21 days

    Sold 1,884 shares at $1.90 ($4k)

    Bala Mohan, SVP, Chief Development Officer

    10b5-1 planSold 3.3% of holdings ($108k position)54,731 shares left0.5x usual sizeFollows a Form 144Filing

  3. 3 Form 144 notice Mersana Therapeutics, Inc.Notice
    Oct 29, 2024 +1 day

    Filed to sell 1,884 shares ($4k)

    Bala Mohan, Officer

    10b5-1 plan0.7x usual sizeFiling

  4. 4 Form 4 sale Mersana Therapeutics, Inc.Routine
    Jan 14, 2025 +77 days

    Sold 3,253 shares at $0.66 ($2k)

    Bala Mohan, SVP, Chief Development Officer

    10b5-1 planSold 5.1% of holdings ($42k position)60,228 shares left1.2x usual sizeFollows a Form 144Filing

  5. 5 Form 4 sale Mersana Therapeutics, Inc.Routine
    Jan 16, 2025 +2 days

    Sold 5,939 shares at $0.58 ($3k)

    Bala Mohan, SVP, Chief Development Officer

    10b5-1 planSold 7.9% of holdings ($43k position)68,872 shares left1.8x usual sizeFiling

  6. 6 Form 144 notice Mersana Therapeutics, Inc.Notice
    Jan 17, 2025 +1 day

    Filed to sell 3,253 shares ($2k)

    Bala Mohan, Officer

    10b5-1 plan1x usual sizeFiling

  7. 7 Form 144 notice Mersana Therapeutics, Inc.Notice
    Jan 17, 2025 same day

    Filed to sell 5,939 shares ($4k)

    Bala Mohan, Officer

    10b5-1 plan1.8x usual sizeFiling

  8. 8 Form 4 sale Mersana Therapeutics, Inc.Routine
    Oct 27, 2025 +283 days

    Sold 77 shares at $9.90 ($762)

    Bala Mohan, SVP, Chief Development Officer

    10b5-1 planSold 2.6% of holdings ($30k position)2,922 shares left0x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (12)

Form 144 notices and Form 4 sales by Bala Mohan
Source
Oct 27, 2025Oct 28, 2025Mersana Therapeutics, Inc.SVP, Chief Development OfficerForm 4 sale77$7622.6%RoutineSEC
Jan 17, 2025Jan 17, 2025Mersana Therapeutics, Inc.OfficerForm 144 notice5,939$4kNoticeSEC
Jan 17, 2025Jan 17, 2025Mersana Therapeutics, Inc.OfficerForm 144 notice3,253$2kNoticeSEC
Jan 16, 2025Jan 17, 2025Mersana Therapeutics, Inc.SVP, Chief Development OfficerForm 4 sale5,939$3k7.9%RoutineSEC
Jan 14, 2025Jan 15, 2025Mersana Therapeutics, Inc.SVP, Chief Development OfficerForm 4 sale3,253$2k5.1%RoutineSEC
Oct 29, 2024Oct 29, 2024Mersana Therapeutics, Inc.OfficerForm 144 notice1,884$4kNoticeSEC
Oct 28, 2024Oct 29, 2024Mersana Therapeutics, Inc.SVP, Chief Development OfficerForm 4 sale1,884$4k3.3%RoutineSEC
Oct 7, 2024Oct 7, 2024Mersana Therapeutics, Inc.OfficerForm 144 notice13,687$28kNoticeSEC
Oct 3, 2024Oct 7, 2024Mersana Therapeutics, Inc.SVP, Chief Development OfficerForm 4 sale13,687$27k21.4%RoutineSEC
Jan 16, 2024Jan 17, 2024Mersana Therapeutics, Inc.SVP, Chief Development OfficerForm 4 sale3,431$9k19.6%RoutineSEC
Jan 16, 2024Jan 16, 2024Mersana Therapeutics, Inc.OfficerForm 144 notice3,431$10kNoticeSEC
Oct 26, 2023Oct 27, 2023Mersana Therapeutics, Inc.SVP, Chief Development OfficerForm 4 sale1,912$2k18.0%RoutineSEC